Anti-kit antibody formulations and methods
US-2026055193-A1 · Feb 26, 2026 · US
Celldex Therapeutics Inc holds 91 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 91 |
| Recent patents | 19 |
| First publication | Feb 12, 2015 |
| Latest publication | Feb 26, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026055193-A1 · Feb 26, 2026 · US
US-2025346671-A1 · Nov 13, 2025 · US
US-2025154274-A1 · May 15, 2025 · US
US-12297266-B2 · May 13, 2025 · US
US-2025115663-A1 · Apr 10, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026055193-A1 · Feb 26, 2026 · US
US-2025346671-A1 · Nov 13, 2025 · US
US-2025154274-A1 · May 15, 2025 · US
US-12297266-B2 · May 13, 2025 · US
US-2025115663-A1 · Apr 10, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K2039/505 | 74 |
| A61P35/00 | 70 |
| C07K2317/76 | 55 |
| C07K2317/21 | 51 |
| C07K2317/92 | 49 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 91 |
| Human Necessities | 88 |
| Physics | 24 |
| Cross-Sectional Technologies | 3 |
| Operations & Transport | 1 |
Answers are generated from the same data shown on this page.